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Abstract
Rationale: Diaphragm is the main inspiratory respiratory muscle and little is known about diaphragm ultrasound in facio-scapula-
humeral muscular dystrophy, a neuromuscular disease characterized by an asymmetric skeletal muscle involvement.
Patient concerns: Diaphragm function evaluation
Diagnosis: Diaphragm muscle weakness attested by the drop of vital capacity (VC) value from sitting position (74%) to supine
position (46%).
Interventions: A diaphragm ultrasound was performed in supine position, from the anterior subcostal window
Outcomes: We found an opposite side to side hemi diaphragm displacement, either during sniff maneuver or during deep
inspiration maneuver, showing a cranial abnormal reduced motion of the right hemi diaphragm whereas the left hemi diaphragm
moved caudally.
Lessons: Diaphragm weakness may be present with an asymmetric pattern and an opposite motion during inspiration or sniff
manoeuver in facio-scapula-humeral muscular dystrophy. A future study with a systematic evaluation of a greater number of FSHD1
patients will be necessary to characterize this population.
Abbreviations: FSHD = facioscapulohumeral dystrophy; MIP = maximal inspiratory pressure; SNIP = sniff nasal inspiratory
pressure; VC = vital capacity.
Keywords: diaphragm weakness, FSHD1, ultrasound[3,4]1. Introduction
Facioscapulohumeral dystrophy (FSHD) is the third most
common genetic muscular dystrophy, with an estimated preva-
lence of 1/8000.[1,2] This disease is characterized by an
asymmetric muscular involvement, affecting initially the face
and the shoulder girdle, followed by the truncal, humeral and
lower extremity muscles. Among FSHD forms, the autosomal
dominant FSHD1 is the most prevalent one (95%). This disease
results from the loss of a subset of repeated units in the D4Z4Editor: N/A.
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1macrosatellite repeat array (chromosome 4q35) that leads to
an aberrant production of DUX4, a double homeobox
transcription factor with toxic gain of function. Respiration
function may be involved, providing a restrictive pattern [5–7] and
a smaller D4Z4 size seems to be associated with a more severe
form with an earlier onset of disease.[8] We report here a side-to-
side opposite diaphragm motion using sonography in a patient
with FSHD1. Informed consent was obtained from the patient for
this case report.2. Case report
A 61 year-old female with facio-scapulo-humeral dystrophy
(FSHD1) was referred to our unit for evaluation. His past medical
history was pertinent for diabetes mellitus and hypertension.
Initial symptoms appeared at the age of 21 years with shoulder
girdle weakness followed by difﬁculty walking. Clinical exami-
nation disclosed winged scapulae, weakness affecting the
shoulder girdle, the facial, the trunk associated with a steppage
gait. Cardiac function was normal with a left ventricular ejection
fraction at 75%. Vital capacity (VC) value decreased from sitting
position (74%) to supine position (46%), which attests
diaphragm muscle impairment. In addition, sniff nasal inspira-
tory pressure (SNIP) was signiﬁcantly decreased (17cmH2O) as
well as maximal inspiratory pressure (MIP at 12cmH2O), related
to a failure of strength‘s diaphragm muscle. Diaphragm
ultrasound (Vivid E9, GE Medical Systems)) was performed in
[12]
Figure 1. Diaphragm ultrasound imaging in FSHD1. The right hemi diaphragmmoves cranially in an opposite direction during deep inspiration (C) or Sniff maneuver
(A) in comparison with the normal caudal movement of the left hemi-diaphragm during deep inspiration (D) or Sniff maneuver (B). FSHD1= facio-scapulo-humeral
dystrophy.
Fayssoil et al. Medicine (2019) 98:4 Medicinesupine position (45°), using a sector probe M5Sc-D (1.5–4.6
MHz), from the anterior subcostal window. The imaging exam
disclosed an opposite side to side hemi diaphragm displacement,
either during sniff maneuver or deep inspirationmaneuver, with a
cranial abnormal reduced motion of the right hemi diaphragm
whereas the left hemi diaphragm moved caudally during
inspiration or sniff maneuver (Fig. 1).
3. Discussion
Respiratory insufﬁciency is a frequent cause of morbidity and
mortality in neuromuscular disorders. In FSHD1, the typical
clinical pattern includes asymmetric skeletal muscle impairment,
with atrophy and muscle fatty replacement of trapezius, teres
major and serratus anterior.[9] Wheelchair is necessary in 20% of
patients often after the 5th decade.[2] Respiratory function is not
systematically involved, and a restrictive respiratory involvement
was found in 9.8% of the largest published cohort with genetic
conﬁrmation of FSHD.[7] Only 1% of patients needed home
mechanical ventilation in the Dutch FSHD population.[10] The
respiratory insufﬁciency is particularly frequent in the infantile
form and in patients with small D4Z4 repeats sizes.[11] Diaphragm
is themain inspiratory respiratorymuscle and little is knownabout
diaphragm function in this disease. Classical pulmonary function
tests assess global respiratorymuscles function, and adecline inVC
greater than 20% from the sitting to the supine position is2interpreted as an indirect sign of diaphragm weakness. One
study assessed global respiratory muscles and diaphragm using
transdiaphragmatic pressures in FSHD patients [13] and reported a
weakness affecting the expiratory muscles rather than the
inspiratory muscles. Indeed, in FSHD, abdominal muscles—that
are the main expiratory muscles—seem to be early affected, in
association with protuberant abdomen and lumbar lordosis.[10,14]
The Beevor sign may be present, due to selective weakness of the
lower rectus abdominis. Contrarily to the study by Stübgen and
Schultz,[13] that did not ﬁnd any alteration of diaphragm function
in FSHD using transdiaphragmatic pressures measurement, we
found an asymmetric and opposite diaphragm motion in FSHD1
using sonography. This difference can be explained by the fact that
transdiaphragmatic pressures may remain in normal range in
patients with asymmetric diaphragm failure, since transdiaphrag-
matic pressures measure the global diaphragmatic function as the
pressure difference between the pleural pressure (oesophageal) and
the gastric pressure. On the contrary, the use of ultrasound allows
detecting asymmetric diaphragmweakness.[15,16] For the diagnosis
of diaphragm paralysis, chest X ray may have a signiﬁcant
sensibility but a lower speciﬁcity. Fluoroscopy was traditionally
used for the diagnosis of diaphragm paralysis, showing a
paradoxical motion during Sniff manoeuvre but this technique
is currently outdated. Diaphragmatic muscle strength may be
explored by the measurement of maximal static inspiratory
pressure and sniff nasal inspiratory pressure.[17] These noninvasive
[2] Tawil R, Van Der Maarel SM. Facioscapulohumeral muscular
Fayssoil et al. Medicine (2019) 98:4 www.md-journal.commethods showedan excellent correlation (0.99+0.01, p<0.001)
with sniff oesophageal pressure.[17] Ultrasound imaging is a
noninvasive approach for diaphragm analysis and can be coupled
with sniff manoeuvre. In our case, the weakness of diaphragmwas
conﬁrmed by sniff, MIP, delta VC (decrease of VC from sitting to
supine position) measurements and ultrasound imaging. Our
results support the fact that diaphragmmuscle may be impaired in
FSHD1 with an asymmetrical distribution, and the disease seems
thus to not affect only the expiratory respiratory muscles, as
previously described.The diaphragm involvementwas asymmetric
in our case, likewise the asymmetric skeletal muscle involvement, a
hallmark of FSHD1. This was not yet reported in the literature,
except for one study that reported a bilateral diaphragm paralysis
in a patient with FSHD.[18] Diaphragmatic ultrasound could be a
sensitivemonitoring tool in addition to functional respiratory tests.
Our study should be considered as exploratory, since it disclosed
some limitations that need to be addressed: we report the result of
only one patient and we do not perform oesophageal pressure
measurement.Author contributions
Conceptualization: Abdallah Fayssoil, Tanya Stojkovic, Adam
Ogna.
Formal analysis: Pascal Laforet, Anthony Behin.
Investigation: Abdallah Fayssoil, Helene Prigent, Frederic




Visualization: Helene Prigent, Frederic Lofaso, David Orlikow-
ski, Guillaume Bassez, Bruno Eymard.
Writing – original draft: Abdallah Fayssoil.
Writing – review & editing: Abdallah Fayssoil, Tanya Stojkovic,
Adam Ogna, Pascal Laforet, Anthony Behin.
References
[1] Deenen JC, Arnts H, van der Maarel SM, et al. Population-based
incidence and prevalence of facioscapulohumeral dystrophy. Neurology
2014;83:1056–9.3dystrophy. Muscle Nerve 2006;34:1–5.
[3] Tawil R, van der Maarel SM, Tapscott SJ. Facioscapulohumeral
dystrophy: the path to consensus on pathophysiology. Skelet Muscle
2014;4:12.
[4] Upadhyaya M, Lunt PW, Sarfarazi M, et al. DNA marker applicable to
presymptomatic and prenatal diagnosis of facioscapulohumeral disease.
Lancet 1990;336:1320–1.
[5] Santos DB, Boussaid G, Stojkovic T, et al. Respiratory muscle
dysfunction in facioscapulohumeral muscular dystrophy. Neuromuscul
Dis NMD 2015;25:632–9.
[6] Moreira S, Wood L, Smith D, et al. Respiratory involvement in ambulant
and non-ambulant patients with facioscapulohumeral muscular dystro-
phy. J Neurol 2017;264:1271–80.
[7] Scully MA, Eichinger KJ, Donlin-Smith CM, et al. Restrictive lung
involvement in facioscapulohumeral muscular dystrophy. Muscle Nerve
2014;50:739–43.
[8] Lemmers RJ, Goeman JJ, van der Vliet PJ, et al. Inter-individual
differences in CpG methylation at D4Z4 correlate with clinical
variability in FSHD1 and FSHD2. Human Mol Genet 2015;24:659–69.
[9] Gerevini S, Scarlato M, Maggi L, et al. Muscle MRI ﬁndings in
facioscapulohumeral muscular dystrophy. Eur Radiol 2016;26:
693–705.
[10] Wohlgemuth M, van der Kooi EL, van Kesteren RG, et al. Ventilatory
support in facioscapulohumeral muscular dystrophy. Neurology
2004;63:176–8.
[11] Nakagawa M, Matsuzaki T, Higuchi I, et al. Facioscapulohumeral
muscular dystrophy: clinical diversity and genetic abnormalities in
Japanese patients. Intern Med 1997;36:333–9.
[12] Perrin C, Unterborn JN, Ambrosio CD, et al. Pulmonary complications
of chronic neuromuscular diseases and their management. Muscle Nerve
2004;29:5–27.
[13] Stübgen JP, Schultz C. Lung and respiratory muscle function in
facioscapulohumeral muscular dystrophy. Muscle Nerve 2009;39:
729–34.
[14] Shahrizaila N, Wills AJ. Signiﬁcance of Beevor’s sign in facioscapulo-
humeral dystrophy and other neuromuscular diseases. J Neurol Neuro-
surg Psychiatry 2005;76:869–70.
[15] Sarwal A, Walker FO, Cartwright MS. Neuromuscular ultrasound for
evaluation of the diaphragm. Muscle Nerve 2013;47:319–29.
[16] Lloyd T, Tang YM, Benson MD, et al. Diaphragmatic paralysis: the use
of M mode ultrasound for diagnosis in adults. Spinal Cord 2006;44:
505–8.
[17] Héritier F, Rahm F, Pasche P, et al. Sniff nasal inspiratory pressure. A
noninvasive assessment of inspiratory muscle strength. Am J Respir Crit
Care Med 1994;150:1678–83.
[18] Hazenberg A, van Alfen N, Voet NB, et al. Facioscapulohumeral
muscular dystrophy and respiratory failure; what about the diaphragm?
Respir Med Case Rep 2014;14:37–9.
